Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101
Stock Information for Bright Minds Biosciences Inc Ordinary Shares
Loading
Please wait while we load your information from QuoteMedia.